BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 17311922)

  • 41. Anti-diabetic and anti-inflammatory effect of a novel selective 11β-HSD1 inhibitor in the diet-induced obese mice.
    Park SB; Jung WH; Kang NS; Park JS; Bae GH; Kim HY; Rhee SD; Kang SK; Ahn JH; Jeong HG; Kim KY
    Eur J Pharmacol; 2013 Dec; 721(1-3):70-9. PubMed ID: 24135201
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increased glucocorticoid receptor and 11{beta}-hydroxysteroid dehydrogenase type 1 expression in hepatocytes may contribute to the phenotype of type 2 diabetes in db/db mice.
    Liu Y; Nakagawa Y; Wang Y; Sakurai R; Tripathi PV; Lutfy K; Friedman TC
    Diabetes; 2005 Jan; 54(1):32-40. PubMed ID: 15616008
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Glucose-dependent insulinotropic polypeptide reduces fat-specific expression and activity of 11β-hydroxysteroid dehydrogenase type 1 and inhibits release of free fatty acids.
    Gögebakan Ö; Andres J; Biedasek K; Mai K; Kühnen P; Krude H; Isken F; Rudovich N; Osterhoff MA; Kintscher U; Nauck M; Pfeiffer AF; Spranger J
    Diabetes; 2012 Feb; 61(2):292-300. PubMed ID: 22179810
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reciprocal regulation of 11β-hydroxysteroid dehydrogenase 1 and glucocorticoid receptor expression by dexamethasone inhibits human coronary artery smooth muscle cell proliferation in vitro.
    Michas G; Liberman M; Becker KC; Handy DE; Loscalzo J; Leopold JA
    Mol Cell Biochem; 2011 Jan; 346(1-2):69-79. PubMed ID: 20922465
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prenatal programming of metabolic syndrome in the common marmoset is associated with increased expression of 11beta-hydroxysteroid dehydrogenase type 1.
    Nyirenda MJ; Carter R; Tang JI; de Vries A; Schlumbohm C; Hillier SG; Streit F; Oellerich M; Armstrong VW; Fuchs E; Seckl JR
    Diabetes; 2009 Dec; 58(12):2873-9. PubMed ID: 19720800
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 11 beta-hydroxysteroid dehydrogenase type 1 promotes differentiation of 3T3-L1 preadipocyte.
    Liu Y; Sun Y; Zhu T; Xie Y; Yu J; Sun WL; Ding GX; Hu G
    Acta Pharmacol Sin; 2007 Aug; 28(8):1198-204. PubMed ID: 17640483
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 11Beta-hydroxysteroid dehydrogenase type 1 in differentiating omental human preadipocytes: from de-activation to generation of cortisol.
    Bujalska IJ; Walker EA; Tomlinson JW; Hewison M; Stewart PM
    Endocr Res; 2002 Nov; 28(4):449-61. PubMed ID: 12530648
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mechanism of repression of 11β-hydroxysteroid dehydrogenase type 1 by growth hormone in 3T3-L1 adipocytes.
    Muraoka T; Hizuka N; Fukuda I; Ishikawa Y; Ichihara A
    Endocr J; 2014; 61(7):675-82. PubMed ID: 24759003
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 11-Dehydrocorticosterone causes metabolic syndrome, which is prevented when 11β-HSD1 is knocked out in livers of male mice.
    Harno E; Cottrell EC; Keevil BG; DeSchoolmeester J; Bohlooly-Y M; Andersén H; Turnbull AV; Leighton B; White A
    Endocrinology; 2013 Oct; 154(10):3599-609. PubMed ID: 23832962
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Carbonyl reduction of triadimefon by human and rodent 11β-hydroxysteroid dehydrogenase 1.
    Meyer A; Vuorinen A; Zielinska AE; Da Cunha T; Strajhar P; Lavery GG; Schuster D; Odermatt A
    Biochem Pharmacol; 2013 May; 85(9):1370-8. PubMed ID: 23419873
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 11beta-Hydroxysteroid dehydrogenase 1 reductase activity is dependent on a high ratio of NADPH/NADP(+) and is stimulated by extracellular glucose.
    Dzyakanchuk AA; Balázs Z; Nashev LG; Amrein KE; Odermatt A
    Mol Cell Endocrinol; 2009 Mar; 301(1-2):137-41. PubMed ID: 18778749
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The expression of 11β-hydroxysteroid dehydrogenase type 1 and 2 in nasal polyp-derived epithelial cells and its possible contribution to glucocorticoid activation in nasal polyp.
    Kook JH; Kim HJ; Kim KW; Park SJ; Kim TH; Lim SH; Kang SH; Lee SH
    Am J Rhinol Allergy; 2015; 29(4):246-50. PubMed ID: 26163245
    [TBL] [Abstract][Full Text] [Related]  

  • 53. 11β-HSD1 reduces metabolic efficacy and adiponectin synthesis in hypertrophic adipocytes.
    Koh EH; Kim AR; Kim H; Kim JH; Park HS; Ko MS; Kim MO; Kim HJ; Kim BJ; Yoo HJ; Kim SJ; Oh JS; Woo CY; Jang JE; Leem J; Cho MH; Lee KU
    J Endocrinol; 2015 Jun; 225(3):147-58. PubMed ID: 25869616
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Localization and glucocorticoid regulation of 11beta-hydroxysteroid dehydrogenase type 1 mRNA in the male mouse forebrain.
    Pelletier G; Luu-The V; Li S; Bujold G; Labrie F
    Neuroscience; 2007 Mar; 145(1):110-5. PubMed ID: 17207581
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Osteoblastic 11beta-hydroxysteroid dehydrogenase type 1 activity increases with age and glucocorticoid exposure.
    Cooper MS; Rabbitt EH; Goddard PE; Bartlett WA; Hewison M; Stewart PM
    J Bone Miner Res; 2002 Jun; 17(6):979-86. PubMed ID: 12054173
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cell-type specific regulation of the human 11beta-hydroxysteroid dehydrogenase type 1 promoter.
    Andres J; Mai K; Möhlig M; Weickert MO; Bumke-Vogt C; Diederich S; Pfeiffer AF; Bähr V; Spranger J
    Arch Physiol Biochem; 2007 Jun; 113(3):110-5. PubMed ID: 17922306
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Contribution of endogenous glucocorticoids and their intravascular metabolism by 11β-HSDs to postangioplasty neointimal proliferation in mice.
    Iqbal J; Macdonald LJ; Low L; Seckl JR; Yau CW; Walker BR; Hadoke PW
    Endocrinology; 2012 Dec; 153(12):5896-905. PubMed ID: 23125311
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibitors of 11β-hydroxysteroid dehydrogenase type 1 in antidiabetic therapy.
    Wang M
    Handb Exp Pharmacol; 2011; (203):127-46. PubMed ID: 21484570
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tumor necrosis factor-alpha upregulates 11beta-hydroxysteroid dehydrogenase type 1 expression by CCAAT/enhancer binding protein-beta in HepG2 cells.
    Ignatova ID; Kostadinova RM; Goldring CE; Nawrocki AR; Frey FJ; Frey BM
    Am J Physiol Endocrinol Metab; 2009 Feb; 296(2):E367-77. PubMed ID: 19088256
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Regulation of 11β-HSD1 expression during adipose tissue expansion by hypoxia through different activities of NF-κB and HIF-1α.
    Lee JH; Gao Z; Ye J
    Am J Physiol Endocrinol Metab; 2013 May; 304(10):E1035-41. PubMed ID: 23512810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.